Nature Search

An inflammatory biomarker signature of response to CAR-T cell therapy in non-Hodgkin lymphoma

A preinfusion circulatory inflammation biomarker-based signature predicts the likelihood of treatment failure in patients with non-Hodgkin lymphoma who were treated with CAR-T cell therapy, with an inflammatory cluster assignment being prognostic of clinical response and survival outcomes.

Sandeep S. Raj
Teng Fei
Roni Shouval
ResearchOpen Access01 Apr 2025
Nature Medicine

Volume: 31, P: 1183-1194
Humoral vaccine responses following Chimeric Antigen Receptor T-cell therapy for hematological malignancies

Sigrun Einarsdottir
Stephanie Lobaugh
Zainab Shahid
ResearchOpen Access02 Jul 2025
Blood Cancer Journal

Volume: 15, P: 1-9
Low-dose unfractionated heparin prophylaxis is a safe strategy for the prevention of hepatic sinusoidal obstruction syndrome after myeloablative adult allogenic stem cell transplant

Maria Sola
Valkal Bhatt
Doris M. Ponce
Research27 Apr 2022
Bone Marrow Transplantation

Volume: 57, P: 1095-1100
CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results

Prophylactic subcutaneous administration of anakinra, an IL-1 receptor inhibitor, reduced severe immune effector cell-associated neurotoxicity syndrome incidence in patients with relapsed or refractory large B-cell and mantle cell lymphoma treated with anti-CD19 chimeric antigen receptor (CAR) T cells.

Jae H. Park
Karthik Nath
Michel Sadelain
Research03 Jul 2023
Nature Medicine

Volume: 29, P: 1710-1717
Impact of geriatric vulnerabilities on allogeneic hematopoietic cell transplantation outcomes in older patients with hematologic malignancies

Richard J. Lin
Theresa A. Elko
Sergio A. Giralt
Research30 Aug 2019
Bone Marrow Transplantation

Volume: 55, P: 157-164
Virus detection in the cerebrospinal fluid of hematopoietic stem cell transplant recipients is associated with poor patient outcomes: a CIBMTR contemporary longitudinal study

Maheen Z. Abidi
Parameswaran Hari
Marcie Riches
Research29 Jan 2019
Bone Marrow Transplantation

Volume: 54, P: 1354-1360
End-of-life care for older AML patients relapsing after allogeneic stem cell transplant at a dedicated cancer center

Richard J. Lin
Theresa A. Elko
Judith E. Nelson
Research22 Aug 2018
Bone Marrow Transplantation

Volume: 54, P: 700-706
CAR T-cell therapy response varies by extranodal disease site in large B-cell lymphoma

Alejandro Luna
Sean M. Devlin
Roni Shouval
ResearchOpen Access14 Apr 2025
Blood Cancer Journal

Volume: 15, P: 1-11
Treatment failure patterns in early versus late introduction of CAR T-cell therapy in large B-cell lymphoma

Magdalena Corona
Andrew Ip
Roni Shouval
Research01 Feb 2025
Bone Marrow Transplantation

Volume: 60, P: 491-498
Safety and feasibility of chimeric antigen receptor T cell therapy after allogeneic hematopoietic cell transplantation in relapsed/ refractory B cell non-Hodgkin lymphoma

Tania Jain
Craig S. Sauter
Miguel-Angel Perales
Research21 May 2019
Leukemia

Volume: 33, P: 2540-2544
Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma

Ana Alarcon Tomas
Joshua A. Fein
Roni Shouval
Research05 Nov 2022
Leukemia

Volume: 37, P: 154-163
Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma

Kitsada Wudhikarn
M. Lia Palomba
Miguel-Angel Perales
ResearchOpen Access05 Aug 2020
Blood Cancer Journal

Volume: 10, P: 1-11
Impact of allogeneic hematopoietic cell transplantation on immune evasive mechanisms in relapsed refractory large B-cell lymphoma

Richard J. Lin
Caleb Ho
Craig S. Sauter
Correspondence13 May 2020
Bone Marrow Transplantation

Volume: 55, P: 2331-2334
Engraftment kinetics after transplantation of double unit cord blood grafts combined with haplo-identical CD34+ cells without antithymocyte globulin

Ioannis Politikos
Sean M. Devlin
Juliet N. Barker
Research18 Jun 2020
Leukemia

Volume: 35, P: 850-862
Bacterial blood stream infections (BSIs), particularly post-engraftment BSIs, are associated with increased mortality after allogeneic hematopoietic cell transplantation

Celalettin Ustun
Jo-Anne H. Young
Marcie Riches
Research13 Dec 2018
Bone Marrow Transplantation

Volume: 54, P: 1254-1265
Management of prolonged cytopenia following CAR T-cell therapy

Magdalena Corona
Roni Shouval
Parastoo B. Dahi
Correspondence21 Sept 2022
Bone Marrow Transplantation

Volume: 57, P: 1839-1841
Syngeneic hematopoietic stem cell transplantation from HTLV-1 seropositive twin for adult T-cell leukemia-lymphoma

Oscar B. Lahoud
Alison J. Moskowitz
Parastoo B. Dahi
Correspondence22 Jan 2018
Bone Marrow Transplantation

Volume: 53, P: 654-656
Use of anti-thymocyte globulin (ATG) for the treatment of pure red cell aplasia and immune-mediated cytopenias after allogeneic hematopoietic cell transplantation: a case series

Alexandra Gomez-Arteaga
Michael Scordo
Parastoo B. Dahi
Correspondence18 May 2020
Bone Marrow Transplantation

Volume: 55, P: 2326-2330
Geriatric syndromes in 2-year, progression-free survivors among older recipients of allogeneic hematopoietic cell transplantation

Richard J. Lin
Raymond E. Baser
Sergio A. Giralt
Correspondence21 Jul 2020
Bone Marrow Transplantation

Volume: 56, P: 289-292
Favorable long-term outcomes of hematopoietic stem cell transplantation for CMML with myeloablative conditioning, anti-thymocyte globulin, and CD34⁺ selected graft

Richard J. Lin
Matias Sanchez
Hugo Castro-Malaspina
Correspondence23 Oct 2019
Bone Marrow Transplantation

Volume: 55, P: 1632-1634
Pretransplant comprehensive geriatric assessment in hematopoietic cell transplantation: a single center experience

Richard J. Lin
Armin Shahrokni
Sergio A. Giralt
Correspondence09 Mar 2018
Bone Marrow Transplantation

Volume: 53, P: 1184-1187
Strategies to improve outcomes of autologous hematopoietic cell transplant in lymphoma

Parastoo B. Dahi
Hillard M. Lazarus
Sergio A. Giralt
Reviews02 Nov 2018
Bone Marrow Transplantation

Volume: 54, P: 943-960

Search

Filter By:

Search

Quick links